米国ケアテイカメディカル社 お問い合わせは、メディカルテクニカへ #vitalstream_caretaker_メディカルテクニカ #Caretaker_Medical_Tailored_Collaboration #Arteriograph_Tensiomed #Pedcath8_MennenMedical #Robot_nurse #real_nurses #VitalStream #Caretaker_Medical #VitalStream_type1_type2_type3 #メディカルテクニカ_介護_在宅
#VitaStream メディカルテクニカのリンク #VitalStream_caretaker_メディカルテクニカ
http://medicalteknika.g.dgdg.jp/linkvar/
メディカルテクニカ有限会社
!doctype>
2024年7月6日土曜日
Diagnosis and Management of #Fetal_Arrhythmias in the Current Era #Labtech_Holter #VitalStream #Arteriograph24 #VitalStream_caretaker #Labtech_Holter #wavelet_algorithm #メディカルテクニカ #生体情報 #血行動態 #Heart_Vest_gtec #Arteriograph_Tensiomed #Pedcath8_MennenMedical
Diagnosis and Management of Fetal Arrhythmias in the Current Era
by Stacy A. S. Killen 1,*ORCID andJanette F. Strasburger 2ORCID
1
Thomas P. Graham Jr. Division of Pediatric Cardiology, Department of Pediatrics,
Vanderbilt University Medical Center, Monroe Carell Jr. Children’s Hospital at Vanderbilt,
2200 Children’s Way, Suite 5230, Nashville, TN 37232, USA
2
J. Cardiovasc. Dev. Dis. 2024, 11(6), 163; https://doi.org/10.3390/jcdd11060163
Submission received: 15 April 2024 / Revised: 18 May 2024 / Accepted: 20 May 2024 / Published: 24 May 2024
(This article belongs to the Special Issue Congenital Heart Disease: Risk Factors, Prenatal Diagnosis, and Outcomes)
Downloadkeyboard_arrow_down Browse Figures Versions Notes
Abstract
Diagnosis and management of fetal arrhythmias have changed over the past 40–50 years
since propranolol was first used to treat fetal tachycardia in 1975 and
when first attempts were made at in utero pacing for complete heart block in 1986.
Ongoing clinical trials, including the FAST therapy trial for fetal tachycardia and
the STOP-BLOQ trial for anti-Ro-mediated fetal heart block, are working to improve diagnosis and
management of fetal arrhythmias for both mother and fetus.
We are also learning more about how “silent arrhythmias”,
like long QT syndrome and other inherited channelopathies, may be identified
by recognizing “subtle” abnormalities in fetal heart rate, and
while echocardiography yet remains the primary tool for diagnosing fetal arrhythmias,
research efforts continue to advance the clinical envelope for fetal electrocardiography
and fetal magnetocardiography. Pharmacologic management of fetal arrhythmias remains
one of the most successful achievements of fetal intervention. Patience, vigilance,
and multidisciplinary collaboration are key to successful diagnosis and treatment.
Keywords: fetal arrhythmias; fetal bradycardia; fetal tachycardia;
fetal anti-Ro/SSA-mediated heart block; fetal long QT syndrome;
fetal echocardiography; fetal magnetocardiography
1. Introduction
#perioperative_care #caretaker_medical #continuous_cardiac_output #true_invasive_blood_pressure
登録:
コメントの投稿 (Atom)
0 件のコメント:
コメントを投稿